Intracranial Activity of Selpercatinib in Chinese Patients With Advanced RET Fusion-Positive Non-Small-Cell Lung Cancer in the Phase II LIBRETTO-321 Trial
在 II 期 LIBRETTO-321 试验中,Selpercatinib 对中国晚期 RET 融合阳性非小细胞肺癌患者的颅内活性
期刊:Jco Precision Oncology
影响因子:5.6
doi:10.1200/PO.22.00708
Cheng, Ying; Huang, Dingzhi; Zhou, Jianying; Zhou, Chengzhi; Sun, Yuping; Wu, Lin; Guo, Ye; Jingxin, Shao; Zhang, Wanli; Lu, Shun